Reported Feb 5, 2025 · Ongoing
Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by:…
McKesson
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: McKesson · 6555 State Highway 161 · Irving, TX · 75039-2402
Is this the product you have?
- Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only
- Mfd byCELLTRION, INC, Dist
- byPfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01
- Lot codes and dates
Lot# 04647349Exp Date 5/31/2029
- Amount recalled
- 192 vials
Where it was sold
- Nationwide
Why it was recalled
cGMP Deviations: Product intended for quarantine was inadvertently distributed.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new McKesson recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.